-
October 05, 2012
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, Inc. (ISIS), recently ...
-
October 04, 2012
Theravance Inc. (THRX) recently announced that it has entered into an agreement with a privately held, Italy based ...
-
October 04, 2012
Roche Holdings Ltd. (RHHBY), along with the Breast International Group (BIG), recently announced results from its ...
-
October 03, 2012
Johnson & Johnson's (JNJ) Janssen Biotech, Inc. recently entered into a licensing agreement with Astellas Pharma ...
-
October 02, 2012
Roche Holdings Ltd. (RHHBY) recently announced additional results from its phase III EMILIA study, which was ...
-
September 26, 2012
Over the recent past Life Technologies (LIFE) has been focusing on expanding its diagnostics portfolio. To achieve ...
-
September 25, 2012
GlaxoSmithKline plc (GSK) performed disappointingly in the second quarter of 2012, missing the Zacks Consensus ...
-
September 25, 2012
Eli Lilly and Company's (LLY) Cialis (tadalafil) recently received a positive opinion from the Committee for ...
-
September 24, 2012
We have reaffirmed our neutral recommendation on Life Technologies (LIFE) with a target price of $51.00. The ...
-
September 21, 2012
Dr. Reddy's Laboratories (RDY) recently announced the launch of its generic version of GlaxoSmithKline's (GSK) ...
-
September 19, 2012
GlaxoSmithKline plc (GSK) recently announced that it is seeking to expand the label of Synflorix in EU and has ...
-
September 18, 2012
Lannett Company, Inc. (LCI) recently announced that the US Food and Drug Administration (FDA) granted approval to ...
-
September 18, 2012
GlaxoSmithKline (GSK) recently announced it has hiked its stake in Response Genetics Inc. (RGDX), a company focused ...
-
September 18, 2012
We recently reiterated our Neutral recommendation on Auxilium Pharmaceuticals, Inc. (AUXL) which carries a Zacks #3 ...
-
September 18, 2012
In an attempt to develop its diagnostics business, Life Technologies (LIFE) entered into a Master Development ...
-
September 14, 2012
Biogen Idec (BIIB) recently announced that it has sold its royalty and other rights related to GlaxoSmithKline's ...
-
September 14, 2012
New York, September 14th (TradersHuddle.com) - Shares of GlaxoSmithKline plc (NYSE:GSK) closed the session at ...
-
September 13, 2012
Abbott Laboratories (ABT) recently announced that it is collaborating with Astellas Pharma Global Development for a ...
-
September 12, 2012
Dr. Reddy's Laboratories (RDY) recently announced the launch of its generic version of AstraZeneca's (AZN) ...
-
September 06, 2012
New York, September 6th (TradersHuddle.com) - Shares of GlaxoSmithKline plc (NYSE:GSK) are trading
very close to ...
